Management of papillary lesions of the breast diagnosed by core biopsy: Need for an evidence-based standard of care [0.03%]
细针穿刺活检确诊的乳头病变的治疗：制定以证据为基础的治疗常规的必要性
Stephen A Feig
Stephen A Feig
Phyllodes tumor with extensive intraductal spread radiologically mimicking ductal carcinoma in situ [0.03%]
影像学表现为广泛管内扩散的叶状肿瘤需与导管原位癌鉴别
Tomoyuki Otani,Mika Hamada,Yukihiko Hashimoto et al.
Tomoyuki Otani et al.
Case Reports
The breast journal. 2020 Feb;26(2):269-270. DOI:10.1111/tbj.13545 2020
Risk-reducing mastectomy in germline CDH1 mutation carriers: Pathologic findings [0.03%]
CDH1基因突变携带者接受降低风险的乳房切除术的病理结果分析
Carlos A Gianella,Beatriz Bendito,Carola Iglesias et al.
Carlos A Gianella et al.
Mammography volumes and performance of screen readers: Is it time for international consensus? [0.03%]
乳腺X线筛查的阅读量与筛查质量：是时候国际统一了吗？
Julie Cox,Nisha Sharma
Julie Cox
Polymorphous adenocarcinoma of the breast-an exceptionally rare entity: Clinicopathological description of a case and brief review [0.03%]
乳腺多形性腺癌一种极为罕见的疾病：一例临床病理报告及简要述评
Helen J Trihia,Christos Valavanis,Natasa Novkovic et al.
Helen J Trihia et al.
Tulika Singh,Nidhi Prabhakar,Veenu Singla et al.
Tulika Singh et al.
Masson's tumor of the breast: Rare differential for new or recurrent breast cancer-Case report, pathology, and review of the literature [0.03%]
乳腺马松瘤：新发或复发性乳腺癌的罕见鉴别诊断-病例报告、病理及文献综述
Robert Steininger,Michael Bouton,Julie Marsh
Robert Steininger
A 66-year-old woman had a new left breast mass with a prior history of a stage IIIC left breast cancer. She had excision of the mass. The pathology noted intravascular papillary endothelial hyperplasia (IPEH) also known as Masson's tumor. A...
Solid papillary carcinoma of breast; a detailed clinicopathological study of 65 cases of an uncommon breast neoplasm with literature review [0.03%]
乳腺实体乳头状癌的临床病理研究及文献回顾（65例报告）
Muhammad Usman Tariq,Romana Idress,Madiha Bilal Qureshi et al.
Muhammad Usman Tariq et al.
Solid papillary carcinoma (SPC) is an uncommon breast tumor whose prognosis depends on invasive component. We studied clinicopathological features of SPC by reviewing 65 cases. Invasive component was seen in 75.4% cases. Almost all tumors w...
Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer [0.03%]
氟维司群单药作为一线内分泌治疗在转移性乳腺癌患者中的有效性和安全性分析
Karen E Skinner,Temitope Olufade,Mark S Walker et al.
Karen E Skinner et al.
Fulvestrant monotherapy is approved for postmenopausal women with hormone receptor-positive, metastatic breast cancer (MBC) who progressed following antiendocrine therapy, or those with hormone receptor-positive, human epidermal receptor 2-...
Observational Study
The breast journal. 2020 Feb;26(2):112-119. DOI:10.1111/tbj.13492 2020
A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy [0.03%]
术后乳房切除术放疗的疗效和安全性的回顾性分析
Justyna Bochenek-Cibor,Filip Georgiew,Sharad Goyal
Justyna Bochenek-Cibor
The data supporting hypofractionated post-mastectomy radiotherapy is limited. The purpose of this study is to present the experience from Tarnów of hypofractionated PMRT over 20 fractions with respect to toxicity and effectiveness. We deli...